TNNI3 and coronary artery disorder: The median (Q1-3) hs-cTnI concentration was 2.3 (1.4–4.7) ng/L in patients with CAD50, 1.5 (1.0–2.6) ng/L in patients with non-obstructive CAD, and 1.3 (0.8–2.4) ng/L in patients without CAD, p < 0.001 for both comparisons.